Acute Porphyria Drugs

A08AB01 - Orlistat

Not porphyrinogenic
NP

Rationale
Insignificant absorption.
Chemical description
Inhibitor of gastrointestinal lipase used in attempts at weight reduction.Given perorally in a dose of 360 mg/d .Metabolized in the gastrointestinal wall, producing two metabolites. Only insignificant absorbtion, plasma concentration < 10 ng/mL.
IPNet drug reports
Uneventful use reported in 2 patients with acute porphyria.
Similar drugs
Explore alternative drugs in similar therapeutic classes A08A / A08AB or go back.
References
Tradenames

Alli · Orlistat · Xenical Alli · Orlistat · Xenical Alli · Beacita · Elimens · Linestat · Normofit · Normostat · Orlidunn · Orliloss · Orlistat · Xenical alli · Xenical Xenical Orlistat · Xenical Alli · Beacita · Orlistat · Orlos · Xenical alli · Orlistat · Xenical Xenical Alli · Xenical Xenical Alli · Xenical alli · Xenical Alli · Orlistat · Xenical alli · Beacita · Orlistat · Xenical Alli · Orlistat · Xenical Alli · Orlistat · Xenical alli · Xenical Alli · Xenical Alli · Beacita · Xenical Orlistat
In cooperation with IpNet
© NAPOS 2025
An unhandled error has occurred. Reload 🗙